| Expression pattern: |
UP |
| Associated gene: |
PTBP1, TNFAIP6 mRNA, TNFAIP6, p65 |
| Associated microRNA: |
- |
| Biological function: |
Promotes gastric cancer cell proliferation, migration, invasion, EMT and tumor growth; circ_0002019 knockdown inhibits these malignant phenotypes. |
| Molecular mechanism: |
circ_0002019 recruits/binds PTBP1 to increase TNFAIP6 mRNA stability, thereby activating TNFAIP6/NF-kappaB signaling in gastric cancer. |
| Biological pathway or process: |
NF-kappaB (promotes); proliferation (promotes); migration (promotes); invasion (promotes); EMT (promotes); metastasis (promotes); mRNA stability (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Transfection; CCK8; EdU Staining; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
circ_0002019 is elevated in gastric cancer tissues and cells, is higher in metastatic GC tissue than non-metastatic GC tissue, and may have therapeutic value in GC treatment. |
| Description: |
hsa_circ_0002019 is up-regulated in gastric cancer tissues and cells and is associated with metastatic GC tissue. It promotes GC proliferation, migration, invasion, EMT and tumor growth by binding PTBP1, increasing TNFAIP6 mRNA stability, and activating TNFAIP6/NF-kappaB signaling. Silencing circ_0002019 suppresses malignant phenotypes in vitro and inhibits xenograft tumor growth in vivo. |
| Confidence score: |
0.835 |